[MDGL] QoQ Quarter Result on 31-Mar-2019 [#Q1]

Stock
[MDGL] Madrigal Pharmaceuticals, Inc.
Announcement Date
08-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -31.42%
YoY- -136.96%
Quarter Report
MDGL's Result
MDGL's Financial Summary
View:
Show?
Quarter Result
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -27,740 -21,429 -19,699 -15,080 -11,475 -8,512 -6,460 163.48%
Tax -28 0 0 0 -25 0 -1,166 -91.61%
NP -27,740 -21,429 -19,699 -15,080 -11,475 -8,512 -6,460 163.48%
Tax Rate - - - - - - - -
Total Cost 27,740 21,429 19,699 15,080 11,475 8,512 6,460 163.48%
Ratio Analysis
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
EPS -1.80 -1.39 -1.28 -0.98 -0.75 -0.56 -0.45 151.34%
EPS Diluted -1.80 -1.39 -1.28 -0.98 -0.75 -0.56 -0.45 151.34%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.